Page 2 - Gerry Coghlan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vicore strengthens rare lung disease pipeline with PAH indication

/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the Angiotensin II type 2.

United kingdomCity ofVastra gotalands lanVicore pharmaGerry coghlanChris dentonCarl johan dalsgaardUniversity college londonRoyal free national pulmonary hypertension serviceNational pulmonary hypertension physicians associationPrnewswire vicore pharma holdingVicore pharma holdingCentre for rheumatologyProfessor chris dentonJoint directorRoyal free hospital

Vicore strengthens rare lung disease pipeline with PAH indication

Vicore strengthens rare lung disease pipeline with PAH indication - read this article along with other careers information, tips and advice on BioSpace

United kingdomCity ofVastra gotalands lanVicore pharmaGerry coghlanChris dentonCarl johan dalsgaardUniversity college londonCompany codesRoyal free national pulmonary hypertension serviceNational pulmonary hypertension physicians associationVicore pharma holdingCentre for rheumatologyProfessor chris dentonJoint directorRoyal free hospital

Vicore to host R&D Day

/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2.

United statesUnited kingdomVastra gotalands lanUniversity of southern californiaLos angelesCity ofVicore pharmaToby maherMaureen hortonGerry coghlanUniversity college londonJohns hopkins universityNational cardiac dublinNational pulmonary hypertension physicians associationRegional health authorityUniversity college dublin

Vicore Pharma Holding AB: Vicore to host R&D Day

GOTHENBURG, Sweden, March 4, 2022 /PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2

United statesUnited kingdomVastra gotalands lanUniversity of southern californiaLos angelesCity ofVicore pharmaToby maherMaureen hortonGerry coghlanCarl johan dalsgaardUniversity college londonJohns hopkins universityNational cardiac dublinNational pulmonary hypertension physicians associationRegional health authority

Early use of Uptravi reduces risk of disease progression in PAH patients

Early use of Uptravi reduces risk of disease progression in PAH patients
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofJanssen uptraviGerry coghlanEuropean society of cardiology congressEuropean societyCardiology congressRoyal free hospital